Cytokine production profile of splenocytes derived from zymosan A-treated SKG mice developing arthritis

被引:20
作者
Kobayashi, K.
Suda, T.
Nan-ya, K.
Sakaguchi, N.
Sakaguchi, S.
Miki, I.
机构
[1] Kyowa Hakko Kogyo Co Ltd, Dept Allergy, Pharmaceut Res Ctr, Nagaizumi, Shizuoka 4418731, Japan
[2] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan
关键词
arthritis; T cell and cytokine;
D O I
10.1007/s00011-006-5208-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: SKG mice have a point mutation of the zeta-associated protein of 70kl) (ZAP-70) and spontaneously develop a severe polyarthritis in the conventional condition, whereas they are healthy under the specific pathogen free (SPF) condition. The purpose of this study was to investigate the cytokine production from splenocytes in SKG mice developing arthritis under the SPF condition. Material: SKG and BALB/c mice were intraperitoneally injected with zymosan A under the SPF condition. Spleen was isolated 1, 2 or 8 weeks after the intraperitoneal injection of saline or zymosan A. Splenocytes were cultured with concanavalin A. Cytokine production and proliferation were measured 48 and 72 h after the culture. Results: An intraperitoneal injection of zymosan A induced severe polyarthritis with increased levels of rheumatoid factor and interleukin 6 (IL-6) only in SKG mice. Splenocytes from SKG mice did not proliferate well maybe because of less productivity of IL-2. The IL-4 production from splenocytes of SKG mice was higher, while interferon-gamma production was lower than those of BALB/c mice. An injection of zymosan A reduced the IL-4 production only in SKG mice. Conclusions: SKG mice do not develop arthritis under the SPF condition possibly because of a low proliferative activity of T cells and Th2-predominance.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 22 条
[1]   Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides [J].
Akdis, CA ;
Kussebi, F ;
Pulendran, B ;
Akdis, M ;
Lauener, RP ;
Schmidt-Weber, CB ;
Klunker, S ;
Isitmangil, G ;
Hansjee, N ;
Wynn, TA ;
Dillon, S ;
Erb, P ;
Baschang, G ;
Blaser, K ;
Alkan, SS .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) :2717-2726
[2]   The role of tumor necrosis factor in the development of multiple organ failure in a murine model [J].
Burdon, D ;
Tiedje, T ;
Pfeffer, K ;
Vollmer, E ;
Zabel, P .
CRITICAL CARE MEDICINE, 2000, 28 (06) :1962-1967
[3]  
Davis SC, 2002, J HIGH ENERGY PHYS
[4]  
Feldmann M, 2001, CURR DIRECT AUTOIMMU, V3, P188
[5]   IL-4 and IL-12 regulate proteoglycan-induced arthritis through stat-dependent mechanisms [J].
Finnegan, A ;
Grusby, MJ ;
Kaplan, CD ;
O'Neill, SK ;
Eibel, H ;
Koreny, T ;
Czipri, M ;
Mikecz, K ;
Zhang, J .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3345-3352
[6]   Evolving concepts of rheumatoid arthritis [J].
Firestein, GS .
NATURE, 2003, 423 (6937) :356-361
[7]   In vivo activated T cells in rheumatoid synovitis.: Analysis of Th1-and Th2-type cytokine production at clonal level in different stages of disease [J].
Gerli, R ;
Bistoni, O ;
Russano, A ;
Fiorucci, S ;
Borgato, L ;
Cesarotti, MEF ;
Lunardi, C .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 129 (03) :549-555
[8]   Early events of TCR signaling are distinct in human Th1 and Th2 cells [J].
Hannier, S ;
Bitegye, C ;
Demotz, S .
JOURNAL OF IMMUNOLOGY, 2002, 169 (04) :1904-1911
[9]   Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice [J].
Hansson, M ;
Djerbi, M ;
Rabbani, H ;
Mellstedt, H ;
Gharibdoost, F ;
Hassan, M ;
DePierre, JW ;
Abedi-Valugerdi, M .
IMMUNOLOGY, 2005, 114 (03) :428-437
[10]   Anti-arthritic effects of KF20444, a new immunosuppressive compound inhibiting dihydroorotate dehydrogenase, on rat collagen-induced arthritis [J].
Kobayashi, K ;
Nakashima, A ;
Nagata, H ;
Nakajima, H ;
Yamaguchi, K ;
Sato, S ;
Miki, I .
INFLAMMATION RESEARCH, 2001, 50 (01) :24-31